# FDA Inspection 1027362 - SCA Pharmaceuticals, Inc. - September 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/sca-pharmaceuticals-inc/47ca0a44-6eb9-44ae-8f35-307f74477bfe
Source feed: FDA_Inspections

> FDA Inspection 1027362 for SCA Pharmaceuticals, Inc. on September 29, 2017. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1027362
- Company Name: SCA Pharmaceuticals, Inc.
- Inspection Date: 2017-09-29
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1281852 - 2025-10-30](https://www.keypedia.com/records/fda_inspections/sca-pharmaceuticals-inc/3b08ca80-27c6-4c30-ae87-5bf29d118329)
- [FDA Inspection 1205440 - 2023-05-17](https://www.keypedia.com/records/fda_inspections/sca-pharmaceuticals-inc/bc538f3c-5f6b-4670-bd0d-9a31a765e5a1)
- [FDA Inspection 1111076 - 2019-11-07](https://www.keypedia.com/records/fda_inspections/sca-pharmaceuticals-inc/5d8b51f3-2eca-4266-8951-c282f239d807)
- [FDA Inspection 877947 - 2014-04-02](https://www.keypedia.com/records/fda_inspections/sca-pharmaceuticals-inc/f8632c29-48f3-4162-ae84-368dfa7c24e2)

Company: https://www.keypedia.com/companies/sca-pharmaceuticals-inc/2ef86fd7-d7d9-4bed-9ad6-24594b9b1f94

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c